Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
12.17
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
12.12
-0.05 (-0.44%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $751.28 million as of September 4, 2026. Its market cap has decreased by -12.26% in one year.
Market Cap
751.28M
Enterprise Value
471.85M
1-Year Change
-12.26%
Ranking
Category
Stock Price
$12.17
ChartMarket Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $751.28M, an increase of 372.31%. That is a compound annual growth rate of 34.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 751.28M | -34.92% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Monopar Therapeutics | 789.08M |
| Aura Biosciences | 784.01M |
| AgomAb Therapeutics NV | 777.13M |
| Neurogene | 772.44M |
| MapLight Therapeutics | 765.28M |
| Phathom Pharmaceuticals | 754.59M |
| Assembly Biosciences | 745.20M |
| Verastem | 742.62M |